Skip to main content

Advertisement

Log in

Complementary and alternative medicine and coping in neuroimmunological diseases

  • Published:
Journal of Neurology Aims and scope Submit manuscript

An Erratum to this article was published on 01 February 2008

Abstract

The utilisation of complementary and alternative medicine (CAM) is widespread in neuroimmunological diseases like multiple sclerosis (MS) but has been disregarded in research until lately. After describing the problems of definition in CAM, different categories will be described.

Various confounding factors on CAM utilisation exist, though hardly investigated. Besides sociodemographic variables like education, income, gender and age, illness-related factors like severity of disease are discussed. Furthermore, the important role of coping and CAM utilisation has not been investigated in neuroimmunological diseases, yet. Results derived from our investigations on CAM utilisation in MS indicate that users of CAM apply coping strategies, such as “rumination”, “search for information” and “search for meaning in religion”, more frequently than non-users and that current CAM utilisation is related to depression. Further research is needed in this field, as well as in other neuroimmunological diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Apel A, Greim B, König N, Zettl UK (2004) The role of coping and depression in utilisation of complementary and alternative medicine by multiple sclerosis patients. Mult Scler 10:138–139

    Google Scholar 

  2. Apel A, Greim B, König N, Zettl UK (2006) Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis. J Neurol 253:1331–1336

    Article  PubMed  Google Scholar 

  3. Apel A, Greim B, Zettl UK (2004) Utilisation of complementary and alternative medicine by multiple sclerosis patients. Mult Scler 10:114–115

    Google Scholar 

  4. Astin JA (1998) Why patients use alternative medicine. JAMA 279:1548–1553

    Article  PubMed  CAS  Google Scholar 

  5. Beekman R, Oosterhuis HJ (1994) Use of alternative treatments by patients with myasthenia gravis. Ned Tijdschr Geneeskd 138:294–296

    PubMed  CAS  Google Scholar 

  6. Berkman CS, Pignotti MG, Cavallo PF, Holland NJ (1999) Use of alternative treatments by people with multiple sclerosis. Neurorehabil Neural Repair 13:243–254

    Article  Google Scholar 

  7. Caspi O, Sechrest L, Pitluk HC, Marshall CL, Bell IR, Nichter M (2003) On the definition of complementary, alternative, and integrative medicine: societal mega-stereotypes vs. the patients' perspectives. Altern Ther Health Med 9:58–62

    PubMed  Google Scholar 

  8. Edelson G, Levy Y, Shoenfeld Y (1999) Relapse of sarcoidosis after alternative medical treatment. Harefuah 136:849–850

    PubMed  CAS  Google Scholar 

  9. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M et al. (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575

    Article  PubMed  CAS  Google Scholar 

  10. Ernst E, Casseleth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83:777–782

    Article  PubMed  CAS  Google Scholar 

  11. Feinstein A (1997) Multiple sclerosis, depression and suicide. BMJ 315:691–692

    PubMed  CAS  Google Scholar 

  12. Kranz R, Rosenmund A (1998) The motivation to use complementary medicine healing methods. Study of a general internal medicine and orthopedic patient sample. Schweiz Med Wochenschr 128:616–622

    PubMed  CAS  Google Scholar 

  13. Launso L (2000) Use of alternative treatments in Denmark: patterns of use and patients' experience with treatment effects. Altern Ther Health Med 6:102–107

    PubMed  CAS  Google Scholar 

  14. MacLennan AH, Wilson DH, Taylor AW (1996) Prevalence and cost of alternative medicine in Australia. Lancet 347:569–573

    Article  PubMed  CAS  Google Scholar 

  15. Moschen R, Kemmler G, Schweigkofler H et al. (2001) Use of alternative/complementary therapy in breast cancer patients – a psychological perspective. Support Care Cancer 9:267–274

    Article  PubMed  CAS  Google Scholar 

  16. National Center of Complementary and Alternative Medicine (NCCAM) (2006) What is complementary and alternative medicine (CAM)? http://nccam.nih.gov/health/whatiscam. Accessed: October 25th 2006

  17. Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC (2003) Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil 17:181–191

    Article  PubMed  Google Scholar 

  18. O'Connor BB, Calabrese C, Cardena C et al. (1997) Defining and describing complementary and alternative medicine. Panel on Definition and Description, CAM Research Methodology Conference, April 1995. Altern Ther Health Med 3:49–57

    Google Scholar 

  19. Plunkett MV, Klein EW, Alldredge BK (2004) Use of complementary and alternative medicine products by persons with epilepsy. Epilepsia 45:148–149

    Google Scholar 

  20. Rajendran PR, Thompson RE, Reich SG (2001) The use of alternative therapies by patients with Parkinson's disease. Neurology 57:790–794

    PubMed  CAS  Google Scholar 

  21. Sadovnik AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K (1996) Depression and multiple sclerosis. Neurology 46:628–632

    Google Scholar 

  22. Schubert DS, Foliart RH (1993) Increased depression in multiple sclerosis patients. A meta-analysis. Psychosomatics 34:124–130

    PubMed  CAS  Google Scholar 

  23. Schwartz CE, Laitin E, Brotman S, LaRocca N (1999) Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology 52:626–629

    PubMed  CAS  Google Scholar 

  24. Shirreffs CM (2001) Aromatherapy massage for joint pain and constipation in a patient with Guillian Barré. Complement Ther Nurs Midwifery 7:78–83

    Article  PubMed  CAS  Google Scholar 

  25. Sirois FM, Gick ML (2002) An investigation of health beliefs and motivations of complementary medicine clients. Soc Sci Med 55:1025–1037

    Article  PubMed  Google Scholar 

  26. Sirven JI, Drazkowski JF, Zimmerman RS, Bortz JJ, Shulman DL, Macleish M (2003) Complementary/alternative medicine for epilepsy in Arizona. Neurology 61:576–577

    PubMed  CAS  Google Scholar 

  27. Stenager E, Stenager EN, Knudsen L, Jensen K (1995) The use of non-medical/alternative treatment in multiple sclerosis. A 5 year follow-up study. Acta Neurol Belg 95:18–22

    PubMed  CAS  Google Scholar 

  28. Stenager EN, Stenager E, Koch-Henriksen N et al. (1992) Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 55:542–545

    Article  PubMed  CAS  Google Scholar 

  29. Vincent C, Furnham A (1997) Complementary medicine: a research perspective. Wiley, Chichester

    Google Scholar 

  30. Wang Y, Hashimoto S, Ramsum D, Findlay B, Best A, Oger J (1999) A pilot study of the use of alternative medicine in multiple sclerosis patients with special focus on acupuncture. Neurology 52:A550

    Google Scholar 

  31. Wasner M, Klier H, Borasio GD (2001) The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci 191:151–154

    Article  PubMed  CAS  Google Scholar 

  32. Winterholler M, Erbguth F, Neundörfer B (1997) The use of alternative medicine by multiple sclerosis patients – patient characteristics and patterns of use. Fortschr Neurol Psychiatr 65:555–561

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Apel.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00415-008-0901-z.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Apel, A., Greim, B. & Zettl, U.K. Complementary and alternative medicine and coping in neuroimmunological diseases. J Neurol 254 (Suppl 2), II112–II115 (2007). https://doi.org/10.1007/s00415-007-2027-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-2027-0

Key words

Navigation